Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

BACKGROUND AND OBJECTIVE: Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP) treated with antifibrotic agents, which has been previously poorly documented. METHODS: We retrospectively examined...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Pulm Med
Main Authors: Kawamura, Kodai, Ichikado, Kazuya, Ichiyasu, Hidenori, Anan, Keisuke, Yasuda, Yuko, Suga, Moritaka, Sakagami, Takuro
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593518/
https://ncbi.nlm.nih.gov/pubmed/31238929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0880-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares